Authors | Year | Time of study, design | Country | No. of patients (lesions) | Inclusion of pretreated patients | Sex (M/F) | Median age (range) | CP-A% | ECOG | Viral etiology (HBV + HCV %) | Inclusion of vascular invasion patients | Median/mean longest diameter (range, cm) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun et al. [10] | 2019 | 2011–2014, R | China | 108 (108) | No | 80/28 | 54 (37–77) | 100% | 0–1 | 89.8% | No | 2.3 (0.7–4.9) |
Parikh et al. [11] | 2018 | 2004–2011, R | USA | 32 (NA) | No | 20/12 | 66 (72,71) IQR | NR | NR | NR | No |  ≤ 5.0 |
Jun et al. [22] | 2018 | 2011–2016, R | Korea | 85 (125) | Yes | 65/20 | Mean 62.6 ± 10 | 83.5% | NR | 68.2% | No | 2.23 ± 1.17 |
Jeong et al. [19] | 2018 | 2012–2013, R | Korea | 119 (139) | Yes | 97/22 | 60 (36–90) | 90.8% | 0–2 | 87.4% | No | 1.7 (≤ 6.0) |
Su et al. [23] | 2016 | 2009–2015, R | China | 132 (175) | Yes | 110/22 | 58 (30–88) | 86.4% | NR | 90.2% (HBV only) | No | 3.0 (1.1–5.0) |
Scorsetti et al. [8] | 2015 | 2010–2014, P | Italy | 43 (63) | Yes | 31/12 | Mean 72 (46–87) | 53.5% | 0–2 | 69.8% | Yes | (≤ 6.0) |
Kimura et al. [24] | 2015 | 2008–2013, R | Japan | 65 (74) | Yes | 44–21 | 73 (49–90) | 86.2% | 0–1 | 90.8% | No | 1.6 (0.5–5.4) |
Shiozawa et al. [12] | 2015 | 2011–2014, R | Japan | 35 (35) | No | 24/11 | Mean 75.1 (55–89) | 80.0% | 0–2 | 77.1% | NR | 2.86 ± 1.15 (1.2–5.0) |
Sanuki et al. [25] | 2014 | 2005–2012, R | Japan | 185 (185) | Yes | 119/66 | 74 (40–89) | 85.4% | NR | 82.2% | Yes | 2.4(0.8–5.0) |
Yoon et al. [9] | 2013 | 2007–2009, R | Korea | 93 (103) | Yes | 75/18 | 61 (42–86) | 74.2% | NR | 87.1% | No | 2.0(≤ 6.0) |
Kwon et al. [16] | 2010 | 2004–2007, R | Korea | 42 (NA) | Yes | 32/10 | Mean 60.1 ± 10.9 | 90.5% | 0–1 | 85.7% | No | (≤ 6.0)a |
Jun et al. [17] | 2018 | 2011–2015, R | Korea | 117 (136) | Yes | 86/31 | 63 (38–85) | 76.1% | NR | 65.0% | No | 2.1 (1.0–4.0) |
Takeda et al. [26] | 2016 | 2007–2012, P | Japan | 90 (90) | Yes | 58/32 | 73 (48–85) | 91.1% | 0–2 | 88.9% | Yes | 2.3 (1.0–4.0) |
Jung et al. [18] | 2013 | 2007–2009, R | Korea | 92 (NA) | Yes | 74/18 | 61 (42–86) | 73.9% | 0–2 | 75.0% (HBV only) | No | (≤ 6.0) |